Trials / Conditions / Androgenetic Alopecia (AGA)

Androgenetic Alopecia (AGA)

21 registered clinical trials studyying Androgenetic Alopecia (AGA) — 14 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia. NCT07529977	Eurofarma Laboratorios S.A.	Phase 3
Not Yet Recruiting	Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth NCT06648850	Applied Biology, Inc.	Phase 2 / Phase 3
Not Yet Recruiting	VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia NCT07536100	Institute of Dermatology, Thailand	N/A
Not Yet Recruiting	The Effect of Nanofat Injection on Androgenetic Alopecia NCT07518342	Assiut University	Phase 4
Recruiting	Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia NCT07370519	Shenzhen People's Hospital	Phase 2
Recruiting	PRP Combined With Botulinum Toxin Type A Injection for the Treatment of Androgenetic Alopecia: A Study NCT07335367	Nanfang Hospital, Southern Medical University	Phase 2
Recruiting	A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia NCT07327359	Olix Pharmaceuticals, Inc.	Phase 1 / Phase 2
Recruiting	Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgeneti NCT07317544	Absci Pty Ltd.	Phase 1 / Phase 2
Recruiting	Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA) NCT07146022	Veradermics, Inc.	Phase 3
Not Yet Recruiting	Low Dose Oral Minoxdil in Androgenic Alopecia NCT07018349	Jinnah Postgraduate Medical Centre	N/A
Recruiting	Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia NCT07012486	Shanghai Zhongshan Hospital	EARLY_Phase 1
Active Not Recruiting	A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia. NCT07011485	PDFE Pharma Innovations FZCO	Phase 2
Enrolling By Invitation	The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. NCT06764329	National Institute of Blood and Marrow Transplant (NIBMT), Pakistan	Phase 1 / Phase 2
Completed	Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia NCT07076706	Beijing Dayspring Pharmaceutical Technology Co., Ltd	Phase 2
Completed	Evaluation of the Dietary Supplement Efficacy Against Hair Loss in Subjects Suffering From Hair Loss NCT07358403	Lacer S.A.	N/A
Not Yet Recruiting	To Evaluate Efficacy and Safety of TopicalKX-826 Solution in Chinese Male Patients With Androgenetic Alopecia NCT06622824	Suzhou Kintor Pharmaceutical Inc,	Phase 2 / Phase 3
Completed	Phase I Clinical Trial of CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia NCT07038941	Beijing Dayspring Pharmaceutical Technology Co., Ltd	Phase 1
Recruiting	Thulium Laser and Growth Factors for Androgenetic Alopecia NCT07079657	Universitätsklinikum Hamburg-Eppendorf	N/A
Completed	Phase II Study Evaluating the Efficacy and Safety of KX-826 NCT05940506	Suzhou Kintor Pharmaceutical Inc,	Phase 2
Completed	Therapeutic Potential of Topical Latanoprost Acid in Hair Loss - Pilot, Proof-of-concept Study NCT07412587	Medical University of Warsaw	N/A
Completed	A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs NCT01900041	Merz Pharmaceuticals GmbH	Phase 2